Menu
ncarol.com
  • Home
  • Music
  • Books
  • Manufacturing
  • Asheville Music
  • Health
  • Book Release
  • Business
  • Technology
ncarol.com

Angels for Change 2024 Drug Shortage Guardian Awarded to Fresenius Kabi USA
ncarol.com/10262612

Trending...
  • FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
  • Heritage at Manalapan Welcomes New Sales Team as Luxury Single-Family Home Community Continues to Grow
TAMPA, Fla. - ncarol.com -- Angels for Change, a global non-profit on a mission to end drug shortages, presented the organization's 2024 Drug Shortage Guardian Award to Fresenius Kabi USA, a health care company that specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition.

Fresenius Kabi USA received the award in recognition of its exceptional teamwork and patient focus during the critical chemotherapy shortages of 2023. The patient-centric focus and culture of Fresenius Kabi enabled the company to rapidly increase output and urgently steward emergency supply to thousands of customers and patients in need of critical therapies.

The Drug Shortage Guardian Award is presented annually to an organization and its people for exhibiting exceptional patient-centered work during a drug shortage crisis. Angels for Change defines a guardian as a "defender; one who guards, protects those in need."

"It is important to recognize individuals within the supply chain for extraordinary, patient-focused work. In highlighting gold-standard work we foster change and support building the resilient supply chain of the future. We are proud to present our 2024 Guardian Award to Fresenius Kabi and its amazing employees who tirelessly strive to ensure patient access to lifesaving medicines across the country, even in dire shortage situations," said Founder and Chief Change Maker of Angels for Change, Laura Bray.

More on ncarol.com
  • FBI/DoW plot uncovered to hurt Trump/Vance through encouraged "widespread" cybersecurity breaches and racketeering theft of $80m in USDA payments
  • Bettingbladet releases H1 2026 report on the Swedish online gambling market
  • Garage door installation or repair in Minnesota? Which makes more sense for your family?
  • Super Rooter Expands to 190 Plumbing, Sewer, and Drain Service Locations Across the United States
  • Google AI Says KayeDinero Isn't the Greatest Female Producer. She Asks: Who Decides?

In addition to recognizing Fresenius Kabi USA, Angels for Change also presented individual Drug Shortage Guardian Awards to two Fresenius employees: Karen Twardzik, Vice President, Customer Service Operations, and Danielle Gross, Manager, Customer Service.

These guardians' extraordinary work and leadership exceeded their normal tasks to navigate within the supply chain to ensure life-saving medicines were delivered to customers and patients experiencing dire shortages. Their heroic efforts helped save lives across the nation.

"At Fresenius Kabi, we exist to put lifesaving medicines and technologies in the hands of people who care for patients. We are honored to receive this recognition from Angels for Change and look forward to supporting the important work of Laura and the mission of Angels for Change. We will continue to do our part to put an end to essential medicine (or drug) shortages," said John Ducker, president and CEO, Fresenius Kabi, Region U.S.

The awards were presented at Fresenius Kabi's U.S. headquarters in Lake Zurich, Ill. on May 16th, 2024. Fresenius Kabi USA leadership and employees joined Angels for Change founder Laura Bray during the award presentation. Following this meeting another presentation occurred at nearby Melrose Park, Ill. where Fresenius Kabi operates a state-of-the art sterile injectable manufacturing site. Here, Bray presented a guardian award to Fresenius Kabi frontline workers who have worked tirelessly to increase supply of needed medicines for patients.

More on ncarol.com
  • European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
  • VICTURY Sports Announces Formation of Youth Sports League Built on the Official, Patented, and Award-Winning Keepy Uppy® Ball
  • From Michael Jackson to Drake: The Artists Who Shaped KayeDinero's Sound
  • L-Tron to Attend the 2026 NC, GA, TN, SC Joint Regional IAI Conference
  • "Kulture Metrics" Isn't Just an Album Title: KayeDinero Connects Music, Markets and Code

About Angels for Change

Angels for Change is a volunteer-supported, global, 501c3 organization started in Tampa, Fla. that is on a mission to end drug shortages through advocacy, awareness, and a resilient supply chain. Founder, Laura Bray, was driven to start Angels for Change after her own child faced three life-saving drug shortages in nine months of pediatric cancer treatment. Each day Angels for Change advocates on behalf of any patient in a life-saving drug shortage, while building relationships with patients and members of the pharmaceutical supply chain to end all healthcare crises created by drug shortages.

www.angelsforchange.org

About Fresenius Kabi USA

Fresenius Kabi, an operating company of Fresenius, is a global healthcare organization that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The company's products and services are used for the therapy and care of patients with critical and chronic conditions. The company is actively involved in efforts to end drug shortages, has invested nearly a billion dollars in U.S. pharmaceutical manufacturing and distribution, and is a past recipient of a Drug Shortage Assistance Award from the U.S. Food and Drug Administration. www.fresenius-kabi.com/us/

Contact
communications@angelsforchanges.org


Source: AngelsForChange.org
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • TekTone innovation meets patient care
  • HydroExcavation.com Relaunches With Exclusive Local Service Areas and Dedicated Hydrovac Manufacturer Directory
  • Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
  • OneVizion Launches Vera AI, Bringing Connected Operational Context to Infrastructure Teams
  • P-Wave Press Announces Pushing the Wave 2025 by L.A. Davenport
  • DONGSHENG Titanium Recycling: Promoting a Closed-Loop Cycle for High-End Titanium Materials
  • Crawler Record for WordPress Version 1.0
  • French Camp Academy Releases New Video Inviting Individuals to Consider a Life of Service
  • Piedmont Crossing Celebrates 40 Years of Caring, Community, and Connection
  • LET US READ Documentary on Dyslexia and Literacy to Screen at TCL Chinese 6 in Hollywood
  • ChatGPT Leans Mostly on Firms' Own Websites to Decide Which Environmental Consultant to Recommend
  • What Does "Human Error" Sound Like North of Asheville? KayeDinero Brings New Era to Weaverville
  • Before Asheville, There Was Cherokee: KayeDinero Reveals Where Her Carolina Chapter Really Began
  • Profit at the Window: Free Webinar Helps Interior Designers Turn Window Treatments Into Revenue
  • Defense & Space Strategy Strengthens as New Leadership Builds on NASA Results and Expanding Multi-Orbit Opportunities for Ascent Solar Technologies
  • STS Capital Partners is pleased to announce the appointment of Barry Brown as Vice President, Business Development
  • Local Ecomaids Owner Launches Healthy Home Reset Initiative for Triangle Families
  • Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
  • Asheville Artist KayeDinero Asks What Happens When Technology Gets Too Human on "Human Error"
  • Heritage at Manalapan Welcomes New Sales Team as Luxury Single-Family Home Community Continues to Grow
_catLbl0 _catLbl1

Popular on ncarol.com

  • Mito Health Passes One Million Lab Tests, Expands to Seven Categories of Preventive Health Testing - 156
  • Parksy (parksy.com) Tackles the Most Common Parking Problem Nobody Talks About: Finding the Car Again - 155
  • Free JavaScript Charting Library ProEssentialsJS Permits Commercial Use. Highcharts, SciChart and LightningChart Free Tiers Do Not - 139
  • 5X Gross Margin Improvement to Beat EPS Consensus; $54.6 Million 10-Year Contract Award Puts Cybersecurity Leader on Path to a $30 Million Run Rate - 133
  • Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A! - 123
  • BumbleBeeSmart Launches Dedicated Sensory Wall Panels Collection for Adults, Memory Care and Senior Living - 122
  • Bspin Launches Lightning-Fast Crypto Gaming Expansion With Sportsbook, Poker, VIP Rewards, and Bitcoin Lightning Network Integration - 122
  • From Temecula Wine Country to Canyon Lake: Parkway Construction Transforms Outdoor Spaces for Inland Homeowners - 121
  • Project CIVICA Report Finds 10,680 Non-Citizen Indicators on New York Voter Rolls — Including 88 Records with Recent Voting History - 119
  • Patented Foodservice Products Company with Strong Gross Margins and Substantial Two-Year Revenue Growth Hits Market for $1.6 Million - 112

Similar on ncarol.com

  • Lawsuit Alleges American Deli Food Caused Severe Illness, Acute Kidney Failure, And Eight-day Hospitalization
  • European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
  • Congressman Chuck Edwards (NC-11) Presents ReadyCommunities Partnership 2026 National Service Award to Local Businessman / US Air Force Veteran
  • White Coat Financial Partners Announces Launch of Next Generation Practice Optimization Software
  • FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
  • French Camp Academy Releases New Video Inviting Individuals to Consider a Life of Service
  • Piedmont Crossing Celebrates 40 Years of Caring, Community, and Connection
  • Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
  • Mandeville Pests May Pose Serious Health Risks for Your Family
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute